<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
10019-098-01
</NDCCode>
<PackageDescription>
10 VIAL in 1 BOX (10019-098-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (10019-098-71)
</PackageDescription>
<NDC11Code>
10019-0098-01
</NDC11Code>
<ProductNDC>
10019-098
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Ceftriaxone
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ceftriaxone Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; INTRAVENOUS
</RouteName>
<StartMarketingDate>
20030930
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA065125
</ApplicationNumber>
<LabelerName>
BAXTER HEALTHCARE CORPORATION
</LabelerName>
<SubstanceName>
CEFTRIAXONE SODIUM
</SubstanceName>
<StrengthNumber>
1
</StrengthNumber>
<StrengthUnit>
g/1
</StrengthUnit>
<Pharm_Classes>
Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-04-06
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
E
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20171231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>